Objective To summarise the available evidence on the risk of myocarditis and/or pericarditis
following mRNA COVID-19 vaccination, compared with the risk among unvaccinated …

Background Information on neurological and psychiatric adverse events following
immunization (AEFIs) with COVID-19 vaccines is limited. Research design & methods We …

Concerns remain regarding the rare cardiovascular adverse events, myocarditis and
pericarditis (myo/pericarditis), particularly in younger individuals following mRNA COVID-19 …

Risk management decisions in public health require consideration of a number of complex,
often conflicting factors. The aim of this review was to propose a set of 10 fundamental …

The COVID-19 pandemic has resulted in over 772 million confirmed cases, including nearly
7 million deaths, according to the World Health Organization (WHO). Leveraging rapid …

Importance There is a high level of public and professional interest related to potential safety
issues of the COVID-19 vaccines; however, no serious adverse cardiovascular events were …

Background During the coronavirus disease 2019 (COVID-19) pandemic, there is an urgent
need for safe and effective COVID-19 vaccines to protect children and adolescents. This …

Introduction Heterologous vaccines enhance the immune response to new variants and
allow flexibility in booster administration when the original vaccine is unavailable. Studies …

Objetiva-se desvelar os motivos para hesitação vacinal de pais e/ou responsáveis de
crianças e adolescentes para prevenção da COVID-19. Trata-se de um estudo descritivo, de …

The incidence of myocarditis and pericarditis has been documented in adolescents after
COVID-19 vaccinations. This study aims to assess the risk of myopericarditis in adolescents …